Q1 Earnings Forecast for ZimVie Issued By B. Riley

ZimVie Inc. (NASDAQ:ZIMV - Free Report) - Stock analysts at B. Riley issued their Q1 2025 EPS estimates for shares of ZimVie in a note issued to investors on Wednesday, April 9th. B. Riley analyst A. Schock anticipates that the company will post earnings per share of ($0.01) for the quarter. B. Riley currently has a "Strong-Buy" rating on the stock. The consensus estimate for ZimVie's current full-year earnings is $0.60 per share. B. Riley also issued estimates for ZimVie's Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at ($0.08) EPS, Q4 2025 earnings at $0.01 EPS, FY2025 earnings at ($0.10) EPS, Q1 2026 earnings at $0.02 EPS, Q2 2026 earnings at $0.07 EPS, Q3 2026 earnings at $0.01 EPS, Q4 2026 earnings at $0.12 EPS and FY2026 earnings at $0.22 EPS.

Separately, Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a research report on Wednesday, April 9th.

ZimVie Stock Performance

NASDAQ:ZIMV traded up $0.14 during mid-day trading on Monday, hitting $9.39. 103,687 shares of the company's stock traded hands, compared to its average volume of 223,715. The firm has a market capitalization of $261.48 million, a price-to-earnings ratio of -0.72 and a beta of 2.14. The firm has a 50 day moving average of $11.55 and a two-hundred day moving average of $13.29. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. ZimVie has a 12 month low of $8.56 and a 12 month high of $22.40.

ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.25 by $0.02. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The firm had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ZIMV. SG Americas Securities LLC increased its stake in ZimVie by 15.7% during the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock valued at $155,000 after acquiring an additional 1,508 shares during the period. EMC Capital Management increased its position in shares of ZimVie by 47.0% during the fourth quarter. EMC Capital Management now owns 13,802 shares of the company's stock valued at $193,000 after purchasing an additional 4,414 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in shares of ZimVie by 5.8% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company's stock valued at $211,000 after purchasing an additional 836 shares during the period. Wells Fargo & Company MN raised its stake in shares of ZimVie by 17.8% in the fourth quarter. Wells Fargo & Company MN now owns 17,037 shares of the company's stock valued at $238,000 after purchasing an additional 2,569 shares in the last quarter. Finally, Principal Financial Group Inc. bought a new position in ZimVie in the third quarter worth $275,000. Institutional investors and hedge funds own 95.63% of the company's stock.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.